You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

carcinoid tumors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoid Tumor Trial in Boston (Ziv-aflibercept)

Active, not recruiting
Has Results
  • Carcinoid Tumor
  • Boston, Massachusetts
  • +2 more
Oct 14, 2022

Carcinoid Tumor, Pancreatic Neuroendocrine Tumor Trial in Boston (Cabozantinib)

Active, not recruiting
  • Carcinoid Tumor
  • Pancreatic Neuroendocrine Tumor
  • Boston, Massachusetts
  • +1 more
Jul 15, 2022

Advanced Carcinoid Tumor, Digestive System Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1 Trial in Houston

Recruiting
  • Advanced Carcinoid Tumor
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Carcinoid Tumors Trial in Boston (Ramucirumab, Somatostatin Analog)

Active, not recruiting
  • Carcinoid Tumors
  • Boston, Massachusetts
  • +1 more
Apr 14, 2022

Carcinoid Tumor, Carcinoid Tumor of GI System, Neuroendocrine Tumors Trial in Boston (Nivolumab, Cabozantinib)

Recruiting
  • Carcinoid Tumor
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jan 14, 2022

Carcinoid Tumor, Metastatic Carcinoid Tumor, Neuroendocrine Tumor Trial in Buffalo, Columbus (Laboratory Biomarker Analysis,

Active, not recruiting
Has Results
  • Carcinoid Tumor
  • +2 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Buffalo, New York
  • +1 more
Nov 8, 2022

Neuroendocrine Tumors, Carcinoid Tumor of GI System, Diarrhea Trial in Lexington (Amino Acid Based Medical Food/Drink)

Completed
  • Neuroendocrine Tumors
  • +3 more
  • Amino Acid Based Medical Food/Drink
  • Lexington, Kentucky
    University of Kentucky Markey Cancer Center
Nov 2, 2022

Neuroendocrine Tumors, Gastrointestinal Tumors, Carcinoid Tumors Trial in Denver, Kansas City, Nashville (Lanreotide, Y-90

Terminated
  • Neuroendocrine Tumors
  • +2 more
  • Denver, Colorado
  • +2 more
Jul 5, 2022

Carcinoid Syndrome, Carcinoid Tumor, Digestive System Neuroendocrine Tumor G1 Trial in Houston (Dual-Energy Computed Tomography)

Recruiting
  • Carcinoid Syndrome
  • +3 more
  • Dual-Energy Computed Tomography
  • Houston, Texas
    M D Anderson Cancer Center
Jul 28, 2021

Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor of Pancreas Trial in Iowa City, Rochester

Not yet recruiting
  • Neuroendocrine Tumors
  • +8 more
  • Iowa City, Iowa
  • +1 more
Nov 23, 2022

Neuroendocrine Tumors, Carcinoid Tumors Trial in Stanford, Tampa (Pasireotide Long Acting Release (LAR))

Active, not recruiting
Has Results
  • Neuroendocrine Tumors
  • Carcinoid Tumors
  • Pasireotide Long Acting Release (LAR)
  • Stanford, California
  • +1 more
Jan 11, 2022

Neuroendocrine Tumors Trial (Telotristat Ethyl Oral Tablet)

Withdrawn
  • Neuroendocrine Tumors
  • Telotristat Ethyl Oral Tablet
  • (no location specified)
Dec 3, 2021

Neuroendocrine Tumors, Carcinoid Syndrome, Diarrhea Trial in Iowa City (Telotristat ethyl, Peptide Receptor Radionuclide

Withdrawn
  • Neuroendocrine Tumors
  • +2 more
  • Telotristat ethyl
  • +2 more
  • Iowa City, Iowa
    University of Iowa Hospital and Clinics
Feb 9, 2022

Small Bowel Cancer, Small Bowel Carcinoid Tumor, Quality of Life Trial in Lorenskog (Surgery with extended (D3) mesenterectomy

Recruiting
  • Small Bowel Cancer
  • +4 more
  • Surgery with extended (D3) mesenterectomy for small bowel tumors
  • Lorenskog, Norway
    Akershus University Hospital
Jan 3, 2023

Advanced Lung Carcinoid Tumor, Functioning Lung Carcinoid Tumor, Locally Advanced Lung Neuroendocrine Tumor Trial in Boston,

Recruiting
  • Advanced Lung Carcinoid Tumor
  • +11 more
  • Boston, Massachusetts
  • +1 more
Jul 19, 2022

Locally Advanced Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in Houston (Placebo Administration, Questionnaire

Recruiting
  • Locally Advanced Neuroendocrine Neoplasm
  • Metastatic Neuroendocrine Neoplasm
  • Placebo Administration
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 31, 2023

Advanced Neuroendocrine Tumor, Carcinoid Syndrome Trial (Retifanlimab, Telotristat Ethyl)

Withdrawn
  • Advanced Neuroendocrine Neoplasm
  • Carcinoid Syndrome
  • Retifanlimab
  • Telotristat Ethyl
  • (no location specified)
Sep 23, 2021

Neuroendocrine Tumors, Carcinoid Tumor, Pulmonary Carcinoid Tumor Trial in Vancouver (177Lu-DOTATOC)

Not yet recruiting
  • Neuroendocrine Tumors
  • +6 more
  • Vancouver, British Columbia, Canada
    BC Cancer
Aug 19, 2022

Carcinoid Tumor Lung, Neuroendocrine Tumor of the Lung, Carcinoma, Small-Cell Lung Trial in Iowa City (212-Lead Pentixather,

Not yet recruiting
  • Carcinoid Tumor Lung
  • +2 more
  • 212-Lead Pentixather
  • 203-Lead Pentixather SPECT/CT
  • Iowa City, Iowa
    The University of Iowa Theranostics Center
Sep 23, 2022

68Ga-DOTATOC Radio-Guided Surgery With ß-Probe in GEP-NET

Recruiting
  • Neuroendocrine Tumor Carcinoid
  • +2 more
    • Milan, Italy
      IRCCS Istituto Europeo di Oncologia S.r.l.
    Jul 8, 2022

    Neuroendocrine Tumors, Carcinoid Tumors, Neuroblastoma Trial in Iowa City (68Ga-DOTATOC PET/CT)

    Completed
    Has Results
    • Neuroendocrine Tumors
    • +3 more
    • 68Ga-DOTATOC PET/CT
    • Iowa City, Iowa
      University of Iowa Health Care
    Jul 24, 2021

    GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease Trial in United States

    Recruiting
    • GEP-NET
    • +6 more
    • Duarte, California
    • +3 more
    Jul 28, 2022

    Gastrinoma, Glucagonoma, Insulinoma Trial in United States (regorafenib, laboratory biomarker analysis)

    Completed
    Has Results
    • Gastrinoma
    • +8 more
    • Scottsdale, Arizona
    • +4 more
    Nov 15, 2021

    DOTATOC PET/CT for Imaging NET Patients

    Recruiting
    • Neuroendocrine Tumors
    • +15 more
    • 68Ga-DOTATOC PET/CT
    • 18F-FDG PET/CT
    • Vancouver, British Columbia, Canada
      BC Cancer
    Nov 2, 2022

    Neuroendocrine Tumors, Carcinoid Tumors, Neuroblastoma Trial in Iowa City (68Ga-DOTATOC PET/CT)

    Completed
    Has Results
    • Neuroendocrine Tumors
    • +3 more
    • 68Ga-DOTATOC PET/CT
    • Iowa City, Iowa
      University of Iowa Hospitals and Clinics
    Dec 17, 2020